The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Ceftriaxone 1g powder for solution for injection/infusion

JED Pharma LimitedPA23183/006/001

Main Information

Trade NameCeftriaxone 1g powder for solution for injection/infusion
Active SubstancesCeftriaxone sodium
Dosage FormSolution for injection/infusion
Licence HolderJED Pharma Limited
Licence NumberPA23183/006/001

Group Information

ATC CodeJ01DD04 ceftriaxone


License statusAuthorised
Licence Issued10/03/2023
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportPDF Version
« Back